CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the main goal of a late-stage trial, sending its shares down…
Missouri appeals court tosses $55 million J&J talc-powder verdict
(Reuters) – A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer…
U.S. medical device firm electroCore IPO price set at $15 per share
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday. ElectroCore, which…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they engaged in schemes to defraud investors, doctors and patients, the…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they engaged in schemes to defraud investors, doctors and patients, the…
Soaring costs, loss of benefits top Americans’ healthcare worries: Reuters/Ipsos poll
(Reuters) – For over a year now, Americans have listed healthcare as the most important problem facing the country, according to Reuters/Ipsos polling. An examination room is seen at an…
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) – A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday in Missouri state court, marking the largest case the company…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries might become a barrier to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs, warning that patients must not be barred from medicines that…
TherapeuticsMD’s therapy for menopause-related condition gets approval
(Reuters) – Women’s healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its hormone therapy for a painful condition triggered by menopause after…